Cardiovascular events and all-cause mortality: effects of dual therapy intensification with insulin vs glucagon-like peptide-1 analogue

被引：0

作者：

Anyanwagu, U. ^{[1
]}

Mamza, J. ^{[1
]}

Mehta, R. ^{[2
]}

Donnelly, R. ^{[1
]}

Idris, I. ^{[1
]}

机构：

[1] Univ Nottingham, Div Med Sci & Grad Entry Med, Nottingham NG7 2RD, England

[2] Univ Nottingham, Trent Res Design Serv, Nottingham NG7 2RD, England

来源：

DIABETOLOGIA | 2015年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

937

引用

页码：S452 / S452

页数：1

共 50 条

[41] Direct cardiovascular effects of glucagon like peptide-1
Asfandyar Sheikh
Diabetology & Metabolic Syndrome, 5
[42] Inventing Liraglutide, a Glucagon-Like Peptide-1 Analogue, for the Treatment of Diabetes and Obesity
Knudsen, Lotte Bjerre
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE, 2019, 2 (06) : 468 - 484
[43] Direct cardiovascular effects of glucagon like peptide-1
Sheikh, Asfandyar
DIABETOLOGY & METABOLIC SYNDROME, 2013, 5
[44] Liraglutide: A once-daily human glucagon-like peptide-1 analogue
Aimaretti, G.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2009, 32 (08) : 701 - 703
[45] Glucagon-like peptide-1: Regulation of insulin secretion and therapeutic potential
Gromada, J
Brock, B
Schmitz, O
Rorsman, P
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2004, 95 (06) : 252 - 262
[46] Liraglutide: A once-daily human glucagon-like peptide-1 analogue
G. Aimaretti
Journal of Endocrinological Investigation, 2009, 32 : 701 - 703
[47] Combining Basal Insulin Analogs with Glucagon-Like Peptide-1 Mimetics
Perfetti, Riccardo
DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (09) : 873 - 881
[48] Future perspectives on glucagon-like peptide-1, diabetes and cardiovascular risk
Mannucci, E.
Rotella, C. M.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2008, 18 (09) : 639 - 645
[49] Insulin-independent actions of glucagon-like peptide-1 in wethers
El-Sabagh, Mabrouk
Taniguchi, Dai
Sugino, Toshihisa
Obitsu, Taketo
Taniguchi, Kohzo
ANIMAL SCIENCE JOURNAL, 2015, 86 (04) : 385 - 391
[50] Use of glucagon-like peptide-1 receptor agonists among individuals on basal insulin requiring treatment intensification
Trautmann, M. E.
Vora, J.
DIABETIC MEDICINE, 2018, 35 (06) : 694 - 706

← 1 2 3 4 5 →